AprilBio Co.,Ltd. (KOSDAQ:397030)

AprilBio Statistics

Total Valuation

AprilBio has a market cap or net worth of KRW 518.13 billion. The enterprise value is 428.28 billion.

Market Cap	518.13B
Enterprise Value	428.28B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

AprilBio has 22.53 million shares outstanding. The number of shares has decreased by -8.17% in one year.

Current Share Class	22.53M
Shares Outstanding	22.53M
Shares Change (YoY)	-8.17%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	31.10%
Owned by Institutions (%)	14.34%
Float	15.29M

Valuation Ratios

The trailing PE ratio is 22.49 and the forward PE ratio is 61.66.

PE Ratio	22.49
Forward PE	61.66
PS Ratio	17.45
PB Ratio	5.61
P/TBV Ratio	5.65
P/FCF Ratio	23.17
P/OCF Ratio	22.89
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.44, with an EV/FCF ratio of 19.15.

EV / Earnings	18.93
EV / Sales	14.43
EV / EBITDA	21.44
EV / EBIT	22.21
EV / FCF	19.15

Financial Position

The company has a current ratio of 11.52, with a Debt / Equity ratio of 0.03.

Current Ratio	11.52
Quick Ratio	11.46
Debt / Equity	0.03
Debt / EBITDA	0.16
Debt / FCF	0.14
Interest Coverage	15.58

Financial Efficiency

Return on equity (ROE) is 30.45% and return on invested capital (ROIC) is 15.25%.

Return on Equity (ROE)	30.45%
Return on Assets (ROA)	13.44%
Return on Invested Capital (ROIC)	15.25%
Return on Capital Employed (ROCE)	20.86%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.33
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.43% in the last 52 weeks. The beta is 1.51, so AprilBio's price volatility has been higher than the market average.

Beta (5Y)	1.51
52-Week Price Change	+14.43%
50-Day Moving Average	17,488.00
200-Day Moving Average	17,558.95
Relative Strength Index (RSI)	81.26
Average Volume (20 Days)	286,409

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AprilBio had revenue of KRW 29.69 billion and earned 22.63 billion in profits. Earnings per share was 1,022.72.

Revenue	29.69B
Gross Profit	29.67B
Operating Income	19.28B
Pretax Income	22.63B
Net Income	22.63B
EBITDA	19.98B
EBIT	19.28B
Earnings Per Share (EPS)	1,022.72

Balance Sheet

The company has 93.07 billion in cash and 3.22 billion in debt, giving a net cash position of 89.85 billion or 3,988.58 per share.

Cash & Cash Equivalents	93.07B
Total Debt	3.22B
Net Cash	89.85B
Net Cash Per Share	3,988.58
Equity (Book Value)	92.33B
Book Value Per Share	4,106.14
Working Capital	89.44B

Cash Flow

In the last 12 months, operating cash flow was 22.64 billion and capital expenditures -271.41 million, giving a free cash flow of 22.37 billion.

Operating Cash Flow	22.64B
Capital Expenditures	-271.41M
Free Cash Flow	22.37B
FCF Per Share	992.83

Margins

Gross margin is 99.94%, with operating and profit margins of 64.94% and 76.23%.

Gross Margin	99.94%
Operating Margin	64.94%
Pretax Margin	76.23%
Profit Margin	76.23%
EBITDA Margin	67.29%
EBIT Margin	64.94%
FCF Margin	75.34%

Dividends & Yields

AprilBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	8.17%
Shareholder Yield	n/a
Earnings Yield	4.37%
FCF Yield	4.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 31, 2023. It was a forward split with a ratio of 2.

Last Split Date	Oct 31, 2023
Split Type	Forward
Split Ratio	2

Scores

AprilBio has an Altman Z-Score of 28.55 and a Piotroski F-Score of 5.

Altman Z-Score	28.55
Piotroski F-Score	5